Why the study?
Does ambulatory blood pressure monitoring better predict target-organ damage, morbidity, and mortality compared to clinic blood pressure measurement in patients with hypertension?
Does ambulatory blood pressure monitoring better predict target-organ damage, morbidity, and mortality compared to clinic blood pressure measurement in patients with hypertension?
Ambulatory blood pressure monitoring is superior to single-session clinic blood pressure measurements in predicting target-organ damage and cardiovascular risk in hypertensive patients.
Answers are grounded in this paper and cite their sources.
Ambulatory monitoring should inform hypertension risk stratification over clinic readings; reinforces guideline preference for out-of-office BP in target-organ assessment.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Verdecchia et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: